Skip to main content

Plasmin-Antiplasmin ELISA

BRD ID: 2030
Tier: SOP
Source: TCP Project
Number of times downloaded: 626

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of plasmin-α2-antiplasmin (PAP) complex in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).